Coreline Soft Showcases Public Healthcare AI Achievements at ‘Softwave 2025’

At the 10th Korea Software Exhibition – Softwave 2025, held from December 3 to 5 at COEX in Seoul, medical AI company Coreline Soft participated in the AI Special Pavilion operated by the National IT Industry Promotion Agency (NIPA). The company noted that its participation was significant not as an independent exhibitor, but as part of the government’s initiative to showcase the成果 of the AI-based Medical System Digital Transformation Support Program.

Over the past year, Coreline Soft completed the first-year project of NIPA’s AI-based Medical System Digital Transformation Support Program, deploying its “4-in-1 Chest AI Platform” across six public medical centers in the Chungcheong region. The integrated system analyzes lung nodules/masses, coronary artery calcification (CAC), COPD, and other abnormalities simultaneously using a single low-dose chest CT scan. By the end of the year, more than 12,000 individuals had benefited from the AI solution during screening and diagnosis. This marks the first adoption of an AI-based integrated chest interpretation system in Korean public medical centers, earning recognition for establishing a practical foundation for reducing regional healthcare disparities and accelerating a nationwide shift toward preventive care.

Coreline Soft has also achieved a string of results in public and industrial R&D this year. In the second half, the company was selected for the 2025 Testbed Seoul Demonstration Program, led by the Seoul Metropolitan Government, and is concurrently conducting a confirmatory clinical trial approved by the Ministry of Food and Drug Safety (MFDS) for its pulmonary embolism (PE) diagnostic AI software, AVIEW iPE. The Testbed program—run by the Seoul Metropolitan Government and the Seoul Business Agency (SBA)—verifies innovative technologies in real clinical settings and supports their path to commercialization.

Additionally, the company is participating in a 22-billion-won national project to develop multimodal AI, creating a next-generation medical AI platform that integrates CT-based multi-disease analysis with generative AI technologies. A company representative stated, “Advancing AI performance and conducting multimodal research will further strengthen our technological competitiveness and align with the integrated platform structures increasingly demanded in global markets.”

Medical AI technology is rapidly emerging as a core component of national essential-healthcare infrastructure. Recent reports from the World Health Organization (WHO) and the OECD emphasize the critical need for AI in diseases where early detection substantially improves survival—such as cancer, cardiovascular disease, and respiratory disorders. Beyond diagnostic accuracy, AI contributes to reducing clinician fatigue and improving regional healthcare accessibility, making B2G (government and public-sector-oriented) trust frameworks increasingly important worldwide.

Through its participation in Softwave 2025, Coreline Soft aims to further strengthen collaboration with national agencies, local governments, and public medical institutions, expanding AI-driven digital transformation across public healthcare. Building on its project achievements, the company also plans to pursue long-term initiatives aligned with national healthcare policies, including public medical-data standardization and the advancement of region-based preventive-care systems.

저작권자 © Korea IT Times 무단전재 및 재배포 금지